Similar observation was made in a previous study demonstrating that rapamycin combined with PI3K inhibitor could induce marked cell death in the de novo resistant melanoma cell lines to PLX4720 by blocking AKT phosphorylation [53]. Here, AKT1 is linked to melanoma.